Hematology TimesFDA lifts clinical hold on AML trialsMarch 10, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsPost-transplant drug combo eyed for high-risk AMLMarch 9, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesStudy reveals higher rate of early death in kids with cancerMarch 7, 2017Leukemia, Myelodysplasia, TransplantationPediatricsAMLALL
Hematology NewsMixed leukemias can benefit from allo-HSTMarch 3, 2017AMLALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesDrug granted priority review for relapsed/refractory AMLMarch 2, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology NewsOlder AML patients benefit from frailty assessment and interventionsFebruary 25, 2017AMLLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Hematology TimesDocs create guideline to aid workup of acute leukemiaFebruary 24, 2017Leukemia, Myelodysplasia, TransplantationAMLALL
Hematology TimesTumor suppressor promotes FLT3-ITD AMLFebruary 22, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesModel illustrates progression to MDS, AMLFebruary 21, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesSite of care may impact survival for AYAs with ALL, AMLFebruary 17, 2017Leukemia, Myelodysplasia, TransplantationAMLALL
Hematology TimesStyrene exposure linked to myeloid leukemia, HLFebruary 16, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLHodgkin LymphomaCMLAggressive Lymphomas
Hematology TimesGroup identifies ‘essential’ genes in AMLFebruary 12, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesComputer predicts remission, relapse in AMLFebruary 10, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAzathioprine may increase risk of MDS, AMLFebruary 7, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesCompany reports third death in SL-401 trialFebruary 4, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML